A new series of 2-amino-3-cyano-4-tetrazoloquinolinylpyridine derivatives has been synthesized by the one-pot cyclocondensation reaction of a tetrazolo[1,5-a]quinoline-4-carbaldehyde, malononitrile, a heterocyclic/aromatic methyl ketone and ammonium acetate. All the synthesized compounds were subjected to in vitro antimicrobial screening against a panel of pathogenic strains of bacteria and fungi. Some of the compounds were found to be equipotent or more potent than commercial antibiotics as evident from the results.
Introduction
Many naturally occurring and synthetic compounds bearing pyridine scaffold possess interesting biological properties. 1 In association with those, 2-amino-3-cyanopyridine derivatives have been identified as IKK-β inhibitors 2 along with its importance and utility as intermediates in preparing variety of heterocyclic compounds. 3 Consequently, the synthesis of 2-amino-3-cyanopyridine derivatives keeps on attracting much interest in organic chemistry. Various routes for the synthesis of 2-amino-3-cyanopyridine derivatives have been reported using two-component as well as three-component reactions. [4] [5] [6] [7] Tu and coworkers have reported a facile synthesis of 2-amino-3-cyanopyridine derivatives in a one-pot reaction using aromatic aldehyde, methyl ketone, malononitrile and ammonium acetate. 4 A literature survey shows that a number of pyridine derivatives have been synthesized using various aldehydes but not a single reference have been found where tetrazolo [1,5-a] quinoline-4-carbaldehyde is used. We wish to report herein this heterocyclic aldehyde which is biologically active [8] [9] [10] with a view to obtaining more active heterocyclic system containing two biologically active moieties quinoline [11] [12] [13] and pyridine 14, 15 together. The most suitable protocol for the synthesis of functionalized organic compounds would be a one-pot reaction due to the fact that the synthesis can be performed without the Hence, in the present investigation, we report an efficient one-pot multicomponent synthesis of 2-amino-3-cyanopyridine derivatives having tetrazoloquinoline nucleus which have also been recognized as promising new scaffold to endow good biological properties 17, 18 such as antiinflammatory and antimicrobial activity.
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Results and Discussion
In the present study, an effort has been made to undertake the synthesis of 2-amino-6-het/aryl-4-(7-(un)-substituted-(tetrazolo[1,5-a]quinolin-4-yl))pyridine-3-carbonitriles through a one step process. For this purpose, the required tetrazolo[1,5-a]quinoline derivatives 1a-c were prepared from 2-chloro-3-formylquinoline and sodium azide by our known literature process. 23 The target compounds 4a-x were prepared in moderate to good yield (52-77%) by the reaction of tetrazolo[1,5-a]quinoline-4-carbaldehyde 1a-c, malononitrile 2, (het)aryl methyl ketone 3a-h and ammonium acetate in absolute alcohol (Scheme 1). The formation of compounds 4a-x may proceed via imine formed from ketone and ammonium acetate, imine reacts with alkylidenemalononitrile formed from Knoevenagel condensation of aldehyde and malononitrile, followed by cycloaddition, isomerization and aromatization to afford the 2-amino-3-cyano-4-tetrazoloquinolinylpyridine derivatives 4a-x. The identity of the product was determined by IR, 1 H NMR, and 13 C NMR spectral studies. The IR spectrum of compound 4a exhibited absorption at 3410 cm -1 (asymmetric N-H stretching) and 3314 cm -1 (symmetric N-H stretching) for -NH 2 , 2214 cm -1 for -CN, 3015 cm -1 for (aromatic C-H stretching) and 1400 to 1600 cm -1 for (C=C aromatic and C=N stretching of pyridine). The 1 H NMR spectra of compound 4a showed the absence of the aldehyde proton, moreover singlets at δ 7.06 ppm and multiplets at δ 7.20-8.71 ppm appeared for amine and aromatic protons respectively. The 13 C NMR spectrum is in good agreement with the structure assigned. All the aromatic carbons of compounds 4a showed signals around δ 115.7-154.3 ppm in the 13 C NMR spectra. The signal at δ 96.0 ppm is assigned to carbon attached with carbonitrile. Besides, the structure of the compound was well confirmed by its mass spectral studies. Mass spectra of compound 4i and 4l gave molecular ion peak at m/z 378 (M+1) and m/z 368 (M+1) corresponding to molecular formula C 22 (MTCC 3008) and Candida albicans (MTCC 227). DMSO was used as vehicle to get desired concentration of compounds to test upon microbial strains. The lowest concentration, which showed no visible growth after spot subculture was considered as MIC for each compound. The standard antibiotics used for comparison in the present study were ampicillin for evaluating antibacterial activity as well as griseofulvin and nystatin for antifungal activity. The protocols are summarized in (Table 1) . Ampi.: Ampicillin, Grise.: Griseofulvin, Nyst.: Nystatin An examination of the data (Table 1 ) reveals that amongst all the synthesized compounds 4a-x, compound 4o exhibited excellent activity against Gram positive bacteria Streptococcus pneumoniae and Gram negative bacteria Vibrio cholerae while compounds 4m and 4w are found to be highly active against Gram negative bacteria Escherichia coli and Salmonella typhi respectively as compared to standard antibiotic ampicillin.
Compounds 4m, 4n, 4q, 4r, 4t and 4w are found to be more potent as compared to standard antibiotic ampicillin against Gram positive bacteria Bacillus subtilis. In case of Gram positive bacteria Clostridium tetani, compounds 4b, 4c, 4g, 4k, 4l, 4s and 4v are found to be more potent than ampicillin.
Antifungal study revealed that compounds 4d, 4g, 4j, 4r, 4t and 4v are more potent as compared to standard fungicidal griseofulvin against Candida albicans. Most of the compounds were not found sufficiently potent to inhibit Aspergillus fumigatus.
Conclusions
A series of some new 2-amino-3-cyano-4-tetrazoloquinolinylpyridine derivatives has been synthesized through a facile one-pot multicomponent reaction. This synthetic strategy allows the construction of relatively complicated nitrogen containing heterocyclic system as well as the introduction of various aromatic and heteroaromatic substitutions into 4-and 6-positions of pyridine. It can be concluded from Table 2 that compound 4o having methyl group on tetrazoloquinoline nucleus and 3-pyridyl substitution on pyridine is highly active against Streptococcus pneumoniae as well as Vibrio cholerae. From the activity data, it is worth mentioning that minor change in molecular configuration of these compounds profoundly influences the activity.
Experimental Section
General. All the reagents were obtained commercially and used with further purification. All melting points were taken in open capillaries and are uncorrected. The monitoring of the progress of all reactions and homogeneity of the synthesized compounds was carried out by TLC. TLC was run using TLC aluminum sheets silica gel 60 F 254 (Merck). Elemental analysis (% C, H, N) was carried out by Perkin Elmer 2400 CHN elemental analyzer at Sophisticated Instrumentation Centre for Applied Research & Training (SICART), Vallabh Vidyanagar. IR spectra were recorded on a Shimadzu FTIR 8401 spectrophotometer in KBr.
1 H NMR and 13 C NMR spectra were recorded on a Bruker Avance 400 MHz spectrometer using solvent peak as internal standard. Mass spectra were scanned on a Shimadzu LCMS 2010 spectrometer.
General procedure for the synthesis of 2-amino-6-het/aryl-4- (7-(un)-substituted-(tetrazolo[1,5-a]quinolin-4-yl) )pyridine-3-carbonitriles 4a-x 7-(Un)substituted-tetrazolo[1,5-a]quinoline-4-carbaldehyde 1a-c (5 mmole), malononitrile 2 (5 mmole), (het)aryl methyl ketone 3a-h (5 mmole), ammonium acetate (40 mmole) and absolute alcohol (15 ml) were charged in a 50 ml round bottom flask. Then, the reaction mixture was refluxed for 2 to 2.5 hr. Progress of reaction was monitored by the TLC. After the completion of reaction, the reaction mixture was cooled to room temperature and stirred for 0.5 hr. The resulting solid was collected by filtration and washed well with absolute alcohol to obtain the pure solid sample of product 4a-x. 
2-Amino-6-phenyl-4-(tetrazolo[1,5-a]quinolin-4-yl)pyridine-
